FARALLON CAPITAL MANAGEMENT, L.L.C.FARALLON CAPITAL MANAGEMENT, L.L.C.

Institutional investor · Portfolio as of Q3 2019

SEC EDGAR SourceSEC Filings

Top Holdings99 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
CELGCELGDelisted

CELGENE CORP

15.6M$1.5B11.7%
3 qtrssince 2019-Q1
Increased
62
AGNAGNDelisted

ALLERGAN PLC

6.2M$1B7.9%
2 qtrssince 2019-Q2
Increased
100
SPYSPY
PUT

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

3.3M$981.1M7.4%
Decreased
AABAAABADelisted
Fund

ALTABA INC

34.2M$666M5.0%
4 qtrssince 2018-Q4
Increased
73
WCGWCGDelisted

WELLCARE HEALTH PLANS INC

2.4M$613.8M4.6%
3 qtrssince 2019-Q1
Increased
62

WABTEC CORP

6.3M$450.6M3.4%$66.40+4.47%
4 qtrssince 2018-Q4
Decreased
0

FIDELITY NATIONAL INFO SERV

3.1M$405.7M3.1%$95.69+20.71%
4 qtrssince 2018-Q4
Increased
62

IQVIA HOLDINGS INC

2.6M$394.4M3.0%$122.21+21.31%
4 qtrssince 2018-Q4
Increased
55
BABABABA
ADR

ALIBABA GROUP HOLDING-SP ADR

2.2M$363.7M2.7%$152.89+3.10%
4 qtrssince 2018-Q4
Increased
86
1.5M$317.7M2.4%
1 qtr
New
80

ALPHABET INC-CL C

250,037$304.8M2.3%$55.49+9.56%
4 qtrssince 2018-Q4
Increased
80

CHARTER COMMUNICATIONS INC - CLASS A

705,309$290.7M2.2%$285.92+42.07%
4 qtrssince 2018-Q4
Increased
53

ANTHEM INC

1.1M$255.2M1.9%$240.68-9.20%
4 qtrssince 2018-Q4
Increased
49

SHERWIN-WILLIAMS CO/THE

449,952$247.4M1.9%$136.78+25.51%
3 qtrssince 2019-Q1
Decreased
0

META PLATFORMS INC-CLASS A

1.4M$242.8M1.8%$146.96+19.67%
4 qtrssince 2018-Q4
Increased
67
PLYAPLYADelisted

PLAYA HOTELS & RESORTS NV

30.6M$239.7M1.8%
4 qtrssince 2018-Q4
Unchanged
0
3.6M$239.1M1.8%
4 qtrssince 2018-Q4
Decreased
0

VISA INC-CLASS A SHARES

1.3M$222.8M1.7%$128.12+27.70%
4 qtrssince 2018-Q4
Increased
53
EQIXEQIX
REIT

EQUINIX INC

371,670$214.4M1.6%$309.48+65.94%
4 qtrssince 2018-Q4
Decreased
0

S&P GLOBAL INC

832,314$203.9M1.5%$198.90+17.58%
3 qtrssince 2019-Q1
Decreased
0
$13.2B
AUM
99
Positions
Q3 2019
Filing
Rating · 1.5
Quarterly Portfolio Change
-3%Q1'19$13.3B+16%Q2'19$15.4B-14%Q3'19$13.2B
Activity profile
$ moved · Q3'19
New11%Increased43%Decreased13%Exited33%
Composition
Equity vs derivatives
Equity92%Puts8%Calls0%
Holding period
Avg 2.4 quarters
<1Q17%1-4Q80%1-2Y0%2Y+3%

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $13.2B across 99 positions as of Q3 2019. Top holdings: CELG (11.7%), AGN (7.9%), SPY (7.4%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.

Q3 2019 Summary

Active quarter - 17 new positions, 23 exits, 47 increased. Top move: AGN (INCREASED, conviction 100). Portfolio: $13.2B across 99 positions.

Top holdings by portfolio weight

Total AUM$12B
CELG11.68%
AGN7.92%
AABA5.03%
WCG4.64%
WAB3.40%
FIS3.06%
IQV2.98%
BABA2.75%
HNIB2.40%
GOOG2.30%
Other2.20%

Portfolio allocation by GICS sector

Sectors9
Unknown51.86%
Healthcare15.72%
Communication Services6.94%
Technology6.63%
Industrials5.97%
Consumer Cyclical4.38%
Financial Services4.38%
Real Estate2.07%
Basic Materials2.05%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Unknown, Healthcare
Compare DNA across all funds
7-dimension quality assessment
Below Average(1.5 / 5.0)
Track Record60
Conviction43
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
CRNXCRNXCRINETICS PHARMACEUTICALS IN
Q3 2024 Q2 2026+8.5M shares+$314.1M
7Q
BBIOBBIOBRIDGEBIO PHARMA INC
Q4 2024 Q2 2026+9M shares+$755.7M
5Q
BSXBSXBOSTON SCIENTIFIC CORP
Q2 2025 Q2 2026+6.8M shares+$69.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used